搜索临床试验以:IQP-AS-119
总计5080个结果
-
Mesoestetic Pharma Group S.L.完全的
-
Shandong UniversityQianfoshan Hospital; Jinan Central Hospital未知
-
University of OxfordMahidol University; Mahidol Oxford Tropical Medicine Research Unit完全的
-
Helse Nord-Trøndelag HFNorwegian University of Science and Technology; VitalThings AS完全的
-
IDP Discovery Pharma S.L.招聘中慢性淋巴细胞白血病 (CLL) | 弥漫性大 B 细胞淋巴瘤,未另行说明 | 多发性骨髓瘤 (MM) | 高级 B 细胞淋巴瘤,未另行说明 | 双发性淋巴瘤 | 三重打击淋巴瘤西班牙
-
Beijing InnoCare Pharma Tech Co., Ltd.招聘中Advanced Solid Tumors Harboring NTRK Fusion | 携带 NTRK 融合的原发性中枢神经系统肿瘤中国
-
University Hospital, Bordeaux尚未招聘肿瘤 | 癌症 | 免疫性血小板减少症 | 免疫性血小板减少性紫癜法国
-
Javier Fandino, MDKaunas University of Technology完全的
-
Beijing InnoCare Pharma Tech Co., Ltd.主动,不招人
-
ImmuPharma完全的
-
Dow Pharmaceutical Sciences未知
-
Symetis SA完全的
-
Institut de Recherches Cliniques de MontrealPharmascience Inc.; SCiAN Services, Inc.; Quercis Pharma AG尚未招聘
-
Vertex Pharmaceuticals Incorporated完全的
-
NFlection Therapeutics, Inc.完全的
-
Wendell Yap, MDUniversity of Kansas Medical Center不再可用
-
Infant Bacterial Therapeutics主动,不招人
-
Yale UniversityNational Center for Complementary and Integrative Health (NCCIH)招聘中